慧俪轻体 WW 深 沪
已收盘 06-26 16:00:00 美东时间
15.99
-0.290
-1.78%
华盛通- 最 高17.32
- 今 开16.01
- 成交量 19.34万股
- 最 低 15.81
- 昨 收 16.28
- 总市值 1.60亿
- 52周最高 46.949
- 市盈率 静 0.15
- 换手率 1.93%
- 52周最低 8.365
- 委 比 70.45%
- 总股本 999.88万
- 历史最高 46.949
- 量 比 0.85
- 振 幅 9.28%
- 历史最低 8.365
- 每 手 1
- 风险率 8.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多WW International And CheqUp Expand Partnership To Deliver Behavioural And Clinical Support For People On Weight Management Journey In UK
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for weight-loss treatment, including access to CheqUp's clinical service in the UK, mirroring the integrated clini...
06-17 04:03
Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
Weight Watchers and CheqUp have expanded their partnership in the UK, integrating clinical and behavioral weight management services. Weight Watchers UK members can now access CheqUp's medical weight loss programs, while CheqUp members continue to benefit from Weight Watchers' app and Core+ program, including the GLP-1 Companion Programme. This collaboration aims to provide a holistic approach to weight loss, combining medical treatment with beha...
06-16 20:01
Hims & Hers Health 在慧俪轻体和礼来的竞争中受挫，首席执行官称赞Anthropic的人工智能突破有望改变医疗行业格局
赫姆斯与赫尔斯健康公司（Hims & Hers Health, Inc.，股票代码：HIMS）股价隔夜下跌1%，投资者权衡其人工智能发展雄心及来自慧俪轻...
06-15 15:24
慧俪轻体扩大GLP - 1药物业务版图，礼来探索肾病新疗法
慧俪轻体国际公司宣布其慧俪轻体平台可通过礼来公司的礼来直达数字医疗平台使用，扩大了获取GLP - 1减肥药物及临床和行为支持服务的途径，这符合慧俪轻体“医疗 ...
06-15 15:14
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Weight Watchers joins LillyDirect for GLP-1 access as Eli Lilly signs a kidney disease research pact with Ascidian worth up to $1.9 billion.
06-05 00:17
WW International, Affiliated Medical Groups Now Accessible Through Eli Lilly's LillyDirect
WW International, Inc. (NASDAQ: WW) and its affiliated medical groups ("Weight Watchers"), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform,
06-04 20:02
Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
Weight Watchers has integrated its Med+ program with Eli Lilly's LillyDirect platform, offering patients enhanced access to GLP-1 medications alongside comprehensive clinical and behavioral support. This collaboration aims to improve weight loss outcomes by combining medication with personalized care, including nutrition guidance and community support. Weight Watchers Med+ is designed to assist patients throughout their weight management journey,...
06-04 12:00
电话会总结 ｜ WW(WW)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 基于WW International业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **第四季度（截至2025年12月31日）核心财务表现：** - 总营收1.63亿美元，同比下降12%，主要由临床业务营收增长32%被行为业务营收下降17%所抵消，外汇收益贡献300万美元 - 调整后EBITDA为1800万美元，EBITDA利润率为11.1% - 调整后毛利率达74.4%，接近历史最高水平，但因季节性临床医生人员配置增加和临床业务收入占比提升而环比略有下降 - 月度ARPU（平均每用户收入）为18.73美元，同比增长8% - 现金及现金等
06-03 12:20
WW International Earnings Call Highlights Clinical Pivot
WW International, Inc. (($WW)) has held its Q1 earnings call. Read on for the m...
06-02 08:37
WW International shares are trading lower after the company reported mixed Q1 financial results and reaffirmed its FY26 sales guidance with its midpoint below estimates.
WW International shares are trading lower after the company reported mixed Q1 f...
05-07 23:02
